LAVA Therapeutics
Why Robinhood?
You can watch LVTX and buy or sell other stocks, ETFs, and their options commission-free!About LVTX
LAVA Therapeutics NV is an immuno-oncology company, which engages in the proprietary Gammabody platform to develop a portfolio of bispecific gamma delta T cell engagers for the potential treatment of solid tumors and hematological malignancies. The company was founded by Erik van den Berg in 2016 and is headquartered in Utrecht, the Netherlands.
LVTX Key Statistics
Stock Snapshot
As of today, LAVA Therapeutics(LVTX) shares are valued at $1.74. The company's market cap stands at 45.77M, with a P/E ratio of -2.02.
On 2026-03-14, LAVA Therapeutics(LVTX) stock opened at —, reached a high of —, and a low of —.
The LAVA Therapeutics(LVTX)'s current trading volume is 0, compared to an average daily volume of 138.76K.
In the last year, LAVA Therapeutics(LVTX) shares hit a 52-week high of $2.00 and a 52-week low of $0.85.
In the last year, LAVA Therapeutics(LVTX) shares hit a 52-week high of $2.00 and a 52-week low of $0.85.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.